|

Controlled Versus Standard Oxygen Therapy in ICU Patients With Acute Exacerbation of COPD

RECRUITINGN/ASponsored by Hôpital Universitaire Taher Sfar
Actively Recruiting
PhaseN/A
SponsorHôpital Universitaire Taher Sfar
Started2026-01-01
Est. completion2027-01-01
Eligibility
Age40 Years+
Healthy vol.Accepted

Summary

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Acute exacerbations frequently require intensive care unit (ICU) admission. Oxygen therapy is an essential component of treatment; however, excessive oxygen administration may aggravate hypercapnia and respiratory acidosis. Current international guidelines recommend titrated oxygen therapy targeting an oxygen saturation of 88-92% in patients with acute exacerbation of COPD, but evidence supporting this strategy in critically ill ICU patients remains limited. This randomized controlled trial aims to compare a controlled oxygen therapy strategy (target oxygen saturation 88-92%) with standard oxygen therapy (oxygen saturation \>94%) in ICU patients admitted with acute exacerbation of COPD. The primary objective is to determine whether controlled oxygen therapy reduces the duration of mechanical ventilation (invasive and non-invasive). Secondary objectives include assessing the 28-day mortality, ICU length of stay, the need for invasive mechanical ventilation, and adverse events related to hyperoxia.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥ 40 years
* Established diagnosis of chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria
* Admission to the intensive care unit for an acute exacerbation of COPD, with or without respiratory acidosis
* Written informed consent provided by the participant or their legally authorized representative

Exclusion Criteria:

* Endotracheal intubation performed before enrollment
* Severe decompensated heart failure with a left ventricular ejection fraction \< 30%
* Active terminal malignancy
* Refusal to participate in the study

Conditions6

Acute Exacerbation of COPDCOPDChronic Obstructive Pulmonary Disease (COPD)Controlled Oxygen TherapyIntensive Care Unit (ICU)Mechanical Ventilation Complication

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.